These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 18663283

  • 21. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 22. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review.
    Daram SR, Cortese CM, Bastani B.
    Am J Kidney Dis; 2005 Oct 01; 46(4):754-9. PubMed ID: 16183432
    [Abstract] [Full Text] [Related]

  • 23. Nephrogenic systemic fibrosis: a dermatologist's perspective.
    Girardi M.
    J Am Coll Radiol; 2008 Jan 01; 5(1):40-4. PubMed ID: 18180008
    [Abstract] [Full Text] [Related]

  • 24. Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation.
    Panesar M, Banerjee S, Barone GW.
    Clin Transplant; 2008 Jan 01; 22(6):803-8. PubMed ID: 18713261
    [Abstract] [Full Text] [Related]

  • 25. [Nephrogenic systemic fibrosis: another problem for patients with chronic renal failure].
    Michelet PR, Chopard CS, Martin PY, Vallée JP.
    Rev Med Suisse; 2008 Mar 05; 4(147):576-8, 580. PubMed ID: 18402015
    [Abstract] [Full Text] [Related]

  • 26. Nephrogenic fibrosing dermopathy: report of two cases.
    Aires NB, Sotto MN, Nico MM.
    Acta Derm Venereol; 2007 Mar 05; 87(6):521-4. PubMed ID: 17989891
    [Abstract] [Full Text] [Related]

  • 27. Nephrogenic fibrosing dermopathy in a patient with acute renal failure never requiring dialysis.
    Cassis TB, Jackson JM, Sonnier GB, Callen JP.
    Int J Dermatol; 2006 Jan 05; 45(1):56-9. PubMed ID: 16426379
    [Abstract] [Full Text] [Related]

  • 28. Imatinib mesylate treatment of nephrogenic systemic fibrosis.
    Kay J, High WA.
    Arthritis Rheum; 2008 Aug 05; 58(8):2543-8. PubMed ID: 18668587
    [Abstract] [Full Text] [Related]

  • 29. Nephrogenic systemic fibrosis in patients undergoing hemodialysis: comment on the article by Todd et al.
    Boehm I.
    Arthritis Rheum; 2008 Mar 05; 58(3):910; author reply 910-1. PubMed ID: 18311835
    [No Abstract] [Full Text] [Related]

  • 30. [Nephrogenic systemic fibrosis].
    Pintér I, Vágási K, Wittmann I, Nagy J.
    Orv Hetil; 2007 Sep 23; 148(38):1801-4. PubMed ID: 17872335
    [Abstract] [Full Text] [Related]

  • 31. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J.
    Ann Rheum Dis; 2008 Dec 23; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [Abstract] [Full Text] [Related]

  • 32. Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review.
    Idée JM, Port M, Medina C, Lancelot E, Fayoux E, Ballet S, Corot C.
    Toxicology; 2008 Jun 27; 248(2-3):77-88. PubMed ID: 18440117
    [Abstract] [Full Text] [Related]

  • 33. Treatment of nephrogenic systemic fibrosis: limited options but hope for the future.
    Linfert DR, Schell JO, Fine DM.
    Semin Dial; 2008 Jun 27; 21(2):155-9. PubMed ID: 18226000
    [Abstract] [Full Text] [Related]

  • 34. Nephrogenic systemic fibrosis with multiorgan involvement in a teenage male after lymphoma, Ewing's sarcoma, end-stage renal disease, and hemodialysis.
    Krous HF, Breisch E, Chadwick AE, Pinckney L, Malicki DM, Benador N.
    Pediatr Dev Pathol; 2007 Jun 27; 10(5):395-402. PubMed ID: 17929984
    [Abstract] [Full Text] [Related]

  • 35. Nephrogenic systemic fibrosis--a rapidly progressive disabling disease with limited therapeutic options.
    Schieren G, Wirtz N, Altmeyer P, Rump LC, Weiner SM, Kreuter A.
    J Am Acad Dermatol; 2009 Nov 27; 61(5):868-74. PubMed ID: 19836645
    [Abstract] [Full Text] [Related]

  • 36. Nephrogenic fibrosing dermopathy: a series in a non-Western population.
    Panda S, Bandyopadhyay D, Tarafder A.
    J Am Acad Dermatol; 2006 Jan 27; 54(1):155-9. PubMed ID: 16384776
    [Abstract] [Full Text] [Related]

  • 37. Nephrogenic systemic fibrosis: more questions and some answers.
    Morcos SK, Thomsen HS.
    Nephron Clin Pract; 2008 Jan 27; 110(1):c24-31; discussion c32. PubMed ID: 18688172
    [Abstract] [Full Text] [Related]

  • 38. Neuromuscular involvement in nephrogenic systemic fibrosis.
    Keyrouz S, Rudnicki SA.
    J Clin Neuromuscul Dis; 2007 Dec 27; 9(2):297-302. PubMed ID: 18090682
    [Abstract] [Full Text] [Related]

  • 39. Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy.
    Cowper SE.
    Am J Kidney Dis; 2005 Oct 27; 46(4):763-5. PubMed ID: 16183434
    [No Abstract] [Full Text] [Related]

  • 40. Localized nephrogenic fibrosing dermopathy: Aberrant dermal repairing?
    Deng AC, Bilu Martin D, Sina B, Gaspari A.
    J Am Acad Dermatol; 2008 Feb 27; 58(2):336-9. PubMed ID: 18222333
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.